Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...
Fintel reports that on October 21, 2025, Stifel reiterated coverage of DexCom (NasdaqGS:DXCM) with a Buy recommendation.